Metraipolis › archive › dc_b49cab5dd337

Daratumumab in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials — Europe PMC PMID:41154406

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41154406
DOI
10.3390/cancers17203349
License (as archived)
solo-consultazione
Archived
2026-11-09T05:36:24.410Z
SHA-256 of the archived text
b579561882c4832322910de67a871821fac8e23993ead0a2c4c7b6255471a4fd
Stable URL of this page
https://metraipolis.com/documento/dc_b49cab5dd337

How to cite

Daratumumab in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials — Europe PMC PMID:41154406 — Europe PMC (en), https://europepmc.org/article/MED/41154406 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b49cab5dd337 (Metraipolis archive dc_b49cab5dd337, sha256 b579561882c4832322910de67a871821fac8e23993ead0a2c4c7b6255471a4fd)
BibTeX
@misc{dcb49cab5dd337,
  title = {Daratumumab in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials — Europe PMC PMID:41154406},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41154406},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b49cab5dd337; sha256 b579561882c4832322910de67a871821fac8e23993ead0a2c4c7b6255471a4fd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41154406. Agents can read the archived copy with the MCP tool read_document.